tiprankstipranks
Trending News
More News >
China Risun Group Ltd. (HK:1907)
:1907
Advertisement

China Risun Group Ltd. (1907) AI Stock Analysis

Compare
0 Followers

Top Page

HK:1907

China Risun Group Ltd.

(Frankfurt:1907)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 4o)
Rating:52Neutral
Price Target:
HK$2.50
▲(6.84% Upside)
The overall stock score is primarily influenced by financial performance and technical analysis. The company shows stable revenue growth but faces significant profitability challenges and high leverage. Technical indicators suggest a bearish trend with potential for reversal, but momentum remains weak. Valuation concerns are heightened by a negative P/E ratio, despite a modest dividend yield.

China Risun Group Ltd. (1907) vs. iShares MSCI Hong Kong ETF (EWH)

China Risun Group Ltd. Business Overview & Revenue Model

Company DescriptionChina Risun Group Ltd. is a leading integrated coke, coking chemical, and refined chemical producer and supplier in China. The company operates across various sectors, including the production and sale of coke, coking chemicals, and refined chemicals, as well as the supply of relevant technologies and services. Its products serve multiple industries, such as steel, chemicals, pharmaceuticals, and agriculture, establishing Risun as a key player in China's industrial supply chain.
How the Company Makes MoneyChina Risun Group Ltd. generates revenue primarily through the production and sale of coke, coking chemicals, and refined chemicals. Coke serves as a crucial raw material for steel manufacturing, and the company capitalizes on its strategic positioning in the supply chain to maintain robust sales. Additionally, Risun's coking chemical products are used in various industrial applications, providing a diversified revenue stream. The company also earns from the sale of refined chemicals, which are utilized in pharmaceuticals, agrochemicals, and other sectors. Strategic partnerships with steel producers and chemical companies enhance its market reach and contribute to its earnings. Furthermore, the provision of technologies and services related to its core products supports additional income avenues.

China Risun Group Ltd. Financial Statement Overview

Summary
China Risun Group Ltd. demonstrates stable revenue growth but faces profitability challenges with a declining net profit margin. The balance sheet reveals high leverage, posing financial risks, though the equity ratio indicates a balanced asset structure. Cash flow generation shows improvement, reflecting operational resilience, but net income volatility remains a concern.
Income Statement
60
Neutral
The company shows a stable revenue growth trend with a Revenue Growth Rate of 3.20% in 2024 compared to 2023. However, the net profit margin has significantly decreased to 0.04% in 2024, indicating profitability challenges. Gross Profit Margin is moderate at 7.34%, and the EBIT Margin has decreased to 2.97% in 2024, suggesting reduced operational efficiency.
Balance Sheet
55
Neutral
The Debt-to-Equity Ratio is relatively high at 2.38, indicating significant leverage, which poses a risk. Return on Equity (ROE) has drastically fallen to 0.16% in 2024, suggesting poor profitability relative to shareholder equity. The Equity Ratio remains moderate at 21.32%, indicating a balanced asset structure but high reliance on debt.
Cash Flow
65
Positive
The Free Cash Flow Growth Rate shows a strong increase, reflecting improved cash generation. However, Operating Cash Flow to Net Income Ratio has weakened due to the drop in net income. The Free Cash Flow to Net Income Ratio is favorable, indicating resilience in cash flow generation despite profitability issues.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue47.54B46.07B43.14B38.43B19.78B
Gross Profit3.49B3.32B4.28B5.53B3.22B
EBITDA3.50B4.37B4.63B5.45B3.22B
Net Income20.13M860.81M1.86B2.61B1.65B
Balance Sheet
Total Assets59.84B53.84B46.10B36.80B24.21B
Cash, Cash Equivalents and Short-Term Investments2.26B1.25B1.40B2.37B1.19B
Total Debt30.38B26.31B20.70B13.80B10.57B
Total Liabilities43.96B39.36B33.51B25.69B15.94B
Stockholders Equity12.76B12.90B12.11B10.98B8.13B
Cash Flow
Free Cash Flow-1.40B134.87M-1.22B534.69M-725.01M
Operating Cash Flow1.44B2.20B3.16B4.21B1.14B
Investing Cash Flow-3.64B-1.71B-9.18B-5.13B-2.19B
Financing Cash Flow3.05B-455.15M4.93B2.02B1.18B

China Risun Group Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.34
Price Trends
50DMA
2.45
Negative
100DMA
2.47
Negative
200DMA
2.58
Negative
Market Momentum
MACD
-0.01
Positive
RSI
37.24
Neutral
STOCH
12.42
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1907, the sentiment is Negative. The current price of 2.34 is below the 20-day moving average (MA) of 2.44, below the 50-day MA of 2.45, and below the 200-day MA of 2.58, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 37.24 is Neutral, neither overbought nor oversold. The STOCH value of 12.42 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1907.

China Risun Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
4.27B7.508.12%6.67%-3.73%6.09%
65
Neutral
3.01B4.0010.84%9.20%213.87%
63
Neutral
869.32M12.124.69%2.58%-8.51%-68.34%
62
Neutral
19.06B13.796.70%0.87%-1.43%113.67%
54
Neutral
1.27B19.753.45%-5.29%-32.47%
52
Neutral
€10.42B486.00-0.52%1.12%-15.17%-125.24%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1907
China Risun Group Ltd.
2.34
-0.79
-25.14%
HK:0609
Tiande Chemical Holdings Limited
1.45
0.31
27.19%
HK:1702
Dongguang Chemical Ltd.
1.40
-0.48
-25.53%
HK:0189
Dongyue Group Limited
11.51
3.82
49.67%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
2.57
0.89
52.98%
HK:0746
Lee & Man Chemical Co. Ltd.
5.17
1.71
49.42%

China Risun Group Ltd. Corporate Events

China Risun Group Secures Shareholder Approval for Key Resolutions at AGM
May 30, 2025

China Risun Group Limited announced that all resolutions proposed at its Annual General Meeting (AGM) held on May 30, 2025, were approved by shareholders. The resolutions included the approval of the company’s financial statements, re-election of directors, re-appointment of the external auditor, and the declaration of a special dividend. The approval of these resolutions reflects strong shareholder support and could positively impact the company’s financial strategy and market perception.

China Risun Group Announces Special Dividend for 2024
May 30, 2025

China Risun Group Limited announced the approval of a special cash dividend of RMB 0.0222 per share for the financial year ending December 31, 2024. The dividend, approved by shareholders on May 30, 2025, will be paid in Hong Kong dollars at a rate of HKD 0.024 per share, with an exchange rate of RMB 1 to HKD 1.077. The ex-dividend date is set for June 9, 2025, and the payment date is June 30, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may enhance its attractiveness to investors.

China Risun Group Announces Major Disposal and Acquisition Transaction
May 18, 2025

China Risun Group Ltd. has announced a significant transaction involving the disposal of equity interests in a target company to Binhai Energy in exchange for consideration shares. This transaction, which includes both a substantial disposal and acquisition, will result in Binhai Energy becoming a subsidiary of Risun Group, thereby consolidating their financial statements. The transaction is subject to various regulatory approvals under the Hong Kong Stock Exchange’s Listing Rules, and further announcements will be made as details are finalized.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 19, 2025